For most aficionados, a sparkling wine can be called champagne only if it comes from the region of France with that name and is made under certain regulations. A new Russian law makes the counter-claim that the word can be used only for Russian wine.

The law has sparked controversy and the renowned winemaker Moet-Hennessy said Monday it was suspending champagne shipments to Russia. The law that was adopted on Friday allows the term to used only for “Russian champagne.”

Since Soviet times, champagne — “shampanskoye” in Russian — has been used as a generic term for a wide range of sparling wines, some of which contradict champagne’s luxury image by selling for as little as 150 rubles ($2) a bottle.

“These provisions lead to a temporary suspension of deliveries of products to assess the impact of this new law,” Moet-Hennessy spokeswoman Anne Catherine Grimal said, according to state news agency RIA-Novosti.

Even the head of one of Russia’s major winemakers thinks the law goes too far.

”For me, there is no doubt that real champagne comes from the Champagne region in France,” Pavel Titov, president of Abrau-Dyurso, told RIA-Novosti. “It is very important to protect Russian wines in our market and provide them with comprehensive patronage. But the legislative measures taken must be reasonable and not contradict common sense.”

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More